RhumbLine Advisers’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-11,014
Closed -$73K 3083
2019
Q1
$73K Buy
11,014
+316
+3% +$2.08K ﹤0.01% 2895
2018
Q4
$77K Buy
10,698
+3,070
+40% +$34.2K ﹤0.01% 2909
2018
Q3
$146K Sell
7,628
-545
-7% -$19.4K ﹤0.01% 2808
2018
Q2
$463K Buy
8,173
+412
+5% +$20.9K ﹤0.01% 2334
2018
Q1
$328K Sell
7,761
-465
-6% -$20K ﹤0.01% 2391
2017
Q4
$440K Sell
8,226
-1,461
-15% -$77.1K ﹤0.01% 2288
2017
Q3
$432K Buy
9,687
+129
+1% +$5.88K ﹤0.01% 2381
2017
Q2
$465K Buy
9,558
+38
+0.4% +$2.24K ﹤0.01% 2345
2017
Q1
$689K Buy
9,520
+289
+3% +$19.1K ﹤0.01% 2109
2016
Q4
$528K Buy
9,231
+782
+9% +$71.6K ﹤0.01% 2198
2016
Q3
$1.08M Buy
8,449
+36
+0.4% +$4.61K ﹤0.01% 1765
2016
Q2
$1.05M Buy
8,413
+808
+11% +$92.9K ﹤0.01% 1755
2016
Q1
$636K Buy
7,605
+536
+8% +$44.2K ﹤0.01% 2054
2015
Q4
$700K Buy
7,069
+600
+9% +$64.3K ﹤0.01% 2039
2015
Q3
$793K Sell
6,469
-51
-0.8% -$6.92K ﹤0.01% 1920
2015
Q2
$1M Sell
6,520
-139
-2% -$22.9K ﹤0.01% 1871
2015
Q1
$1.14M Buy
6,659
+765
+13% +$116K ﹤0.01% 1774
2014
Q4
$901K Sell
5,894
-65
-1% -$8.11K ﹤0.01% 1879
2014
Q3
$632K Buy
5,959
+110
+2% +$15.3K ﹤0.01% 2068
2014
Q2
$890K Sell
5,849
-244
-4% -$32.5K ﹤0.01% 1908
2014
Q1
$784K Sell
6,093
-307
-5% -$47.7K ﹤0.01% 1959
2013
Q4
$1.12M Sell
6,400
-44
-0.7% -$7.56K ﹤0.01% 1739
2013
Q3
$1.04M Sell
6,444
-67
-1% -$10.6K ﹤0.01% 1759
2013
Q2
$865K Buy
+6,511
New +$919K ﹤0.01% 1869

Other funds holding ELGX

RhumbLine Advisers's ELGX Position: Q2 2019 in Review

RhumbLine Advisers sold out of Endologix Inc (ELGX) in Q2 2019, closing a stake of 11,014 shares — an estimated $73K sold.

RhumbLine Advisers first reported a position in ELGX in Q2 2013 and held it in 24 quarters. The position peaked at $1.14M in Q1 2015. 75 funds tracked by Wall St. Rank hold ELGX as of Q2 2019.

  • RhumbLine Advisers reported no remaining Endologix Inc position as of Q2 2019 after selling out during the quarter.
  • RhumbLine Advisers sold 11,014 Endologix Inc shares in Q2 2019, an estimated $73K.
  • RhumbLine Advisers first reported a position in Endologix Inc in Q2 2013 and held it in 24 quarters.
  • RhumbLine Advisers's Endologix Inc position peaked at $1.14M in Q1 2015.
  • 75 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2019.

Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.